NYSE - Delayed Quote USD

The Cigna Group (CI)

279.05 -8.61 (-2.99%)
At close: July 31 at 4:00:03 PM EDT
280.50 +1.45 (+0.52%)
After hours: July 31 at 7:59:16 PM EDT
Trade CI on Coinbase
CI Q2 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for CI

News headlines Cigna (CI) reported strong Q2 2026 earnings with $71.7 billion in revenue and an adjusted EPS of $7.78, exceeding estimates. The company raised its full-year adjusted EPS guidance to at least $30.45, driven by robust performance in its healthcare segment despite regulatory challenges ahead.

Cigna (CI) reported strong Q2 2026 earnings with $71.7 billion in revenue and an adjusted EPS of $7.78, exceeding estimates. The company raised its full-year adjusted EPS guidance to at least $30.45, driven by robust performance in its healthcare segment despite regulatory challenges ahead.

Updated 49m ago · Powered by Yahoo Scout
  • Previous Close 287.66
  • Open 285.11
  • Bid 281.26 x 4000
  • Ask 281.36 x 12000
  • Day's Range 278.98 - 287.35
  • 52 Week Range 239.51 - 315.47
  • Volume 1,731,318
  • Avg. Volume 1,665,792
  • Market Cap (intraday) 73.736B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 11.54
  • EPS (TTM) 24.19
  • Earnings Date Jul 30, 2026
  • Forward Dividend & Yield 6.24 (2.24%)
  • Ex-Dividend Date Sep 8, 2026
  • 1y Target Est 340.92

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

www.thecignagroup.com

65,669

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 7/31/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CI
2.54%
S&P 500 (^GSPC)
9.41%

1-Year Return

CI
6.68%
S&P 500 (^GSPC)
18.15%

3-Year Return

CI
0.11%
S&P 500 (^GSPC)
63.21%

5-Year Return

CI
33.32%
S&P 500 (^GSPC)
70.40%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 71.4B
Earnings 1.66B

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
20B
40B
60B
 

Analyst Insights

View More

Top Analyst

Deutsche Bank
66/100
Latest Rating
Hold
 

Analyst Price Targets

290.00
340.92 Average
279.05 Current
400.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest Rating

Date 7/31/2026
Analyst Wells Fargo
Rating Action Maintains
Rating Equal-Weight
Price Action Raises
Price Target 305 -> 307
 

Statistics

View More

Valuation Measures

Annual
As of 7/30/2026
  • Market Cap

    76.10B

  • Enterprise Value

    100.80B

  • Trailing P/E

    11.90

  • Forward P/E

    9.45

  • PEG Ratio (5yr expected)

    0.86

  • Price/Sales (ttm)

    0.27

  • Price/Book (mrq)

    1.79

  • Enterprise Value/Revenue

    0.36

  • Enterprise Value/EBITDA

    7.88

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.27%

  • Return on Assets (ttm)

    4.46%

  • Return on Equity (ttm)

    16.76%

  • Revenue (ttm)

    282.38B

  • Net Income Avi to Common (ttm)

    6.42B

  • Diluted EPS (ttm)

    24.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.26B

  • Total Debt/Equity (mrq)

    74.29%

  • Levered Free Cash Flow (ttm)

    7.98B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

279.05 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

Research Reports

View More
  • Cigna Earnings: Medical Insurance Margin Progress Constrained by PBM Business Model Transition

    Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.

    Rating
    Price Target
     
  • Raising target price to $331.00

    Cigna Group/The has an Investment Rating of BUY; a target price of $331.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
     
  • Lowering target price to $320.00

    Cigna Group/The has an Investment Rating of BUY; a target price of $320.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
     
  • Raising target price to $334.00

    Cigna Group/The has an Investment Rating of BUY; a target price of $334.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
     

People Also Watch